Literature DB >> 12360485

Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.

Peter Fickert1, Gernot Zollner, Andrea Fuchsbichler, Conny Stumptner, Andreas H Weiglein, Frank Lammert, Hanns-Ulrich Marschall, Oleksiy Tsybrovskyy, Kurt Zatloukal, Helmut Denk, Michael Trauner.   

Abstract

BACKGROUND & AIMS: The effects of ursodeoxycholic acid (UDCA) in biliary obstruction are unclear. We aimed to determine the effects of UDCA in bile duct-ligated and in Mdr2 knockout (Mdr2(-/-)) mice with biliary strictures.
METHODS: Mice fed UDCA (0.5% wt/wt) or a control diet were subjected to common bile duct ligation (CBDL), selective bile duct ligation (SBDL), or sham operation. UDCA was also fed to 2-month-old Mdr2(-/-) mice. Serum biochemistry, liver histology, and mortality rates were investigated. The biliary tract was studied by plastination, India ink injection, and electron microscopy. The effects of UDCA on biliary pressure were determined by cholangiomanometry.
RESULTS: UDCA feeding in CBDL mice increased biliary pressure, with subsequent rupture of cholangioles and aggravation of hepatocyte necroses, resulting in significantly increased mortality. UDCA feeding in SBDL mice aggravated liver injury exclusively in the ligated lobe. Mdr2(-/-) mice developed liver lesions resembling sclerosing cholangitis characterized by biliary strictures and dilatations. UDCA induced bile infarcts in these animals.
CONCLUSIONS: UDCA aggravates bile infarcts and hepatocyte necroses in mice with biliary obstruction via disruption of cholangioles as a result of increased biliary pressure caused by its choleretic action.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12360485     DOI: 10.1053/gast.2002.35948

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  98 in total

Review 1.  Primary sclerosing cholangitis: is any treatment worthwhile?

Authors:  Ashley Barnabas; Roger W Chapman
Journal:  Curr Gastroenterol Rep       Date:  2012-02

2.  Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Methods Mol Biol       Date:  2015

3.  Sulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers.

Authors:  C Rust; K Bauchmuller; C Bernt; T Vennegeerts; P Fickert; A Fuchsbichler; U Beuers
Journal:  Gut       Date:  2005-12-01       Impact factor: 23.059

4.  Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.

Authors:  Peter Fickert; Andrea Fuchsbichler; Hanns-Ulrich Marschall; Martin Wagner; Gernot Zollner; Robert Krause; Kurt Zatloukal; Hartmut Jaeschke; Helmut Denk; Michael Trauner
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

5.  Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion.

Authors:  Nisanne S Ghonem; Meenakshisundaram Ananthanarayanan; Carol J Soroka; James L Boyer
Journal:  Hepatology       Date:  2014-01-27       Impact factor: 17.425

Review 6.  Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology.

Authors:  Tirthadipa Pradhan-Sundd; Satdarshan Pal Monga
Journal:  Gene Expr       Date:  2019-01-15

7.  Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.

Authors:  Benjamin L Woolbright; Daniel J Antoine; Rosalind E Jenkins; Mary Lynn Bajt; B Kevin Park; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2013-10-03       Impact factor: 4.219

8.  Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, live-mouse cholangiography.

Authors:  James H Tabibian; Slobodan I Macura; Steven P O'Hara; Jeff L Fidler; James F Glockner; Naoki Takahashi; Val J Lowe; Bradley J Kemp; Prasanna K Mishra; Pamela S Tietz; Patrick L Splinter; Christy E Trussoni; Nicholas F LaRusso
Journal:  Lab Invest       Date:  2013-04-15       Impact factor: 5.662

Review 9.  Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.

Authors:  Michael Trauner; Peter Fickert; Emina Halilbasic; Tarek Moustafa
Journal:  Wien Med Wochenschr       Date:  2008

10.  Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats.

Authors:  Michele Barone; Eugenio Maiorano; Roberta Ladisa; Antonia Pece; Pasquale Berloco; Mario Strazzabosco; Maria Lucia Caruso; Anna Maria Valentini; Enzo Ierardi; Alfredo Di Leo; Antonio Francavilla
Journal:  Virchows Arch       Date:  2004-04-08       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.